Chairman

• Paul Hastings
  President and Chief Executive Officer, OncoMed Pharmaceuticals

Vice Chairman

• Corey S. Goodman, Ph.D.
  Managing Director and Co-Founder, venBio LLC

Treasurer

• Scott W. Morrison
  Life Science Partner, Ernst & Young LLP

Secretary

• Bruce W. Jenett
  Co-Chair, Global Life Sciences Sector, DLA Piper LLP (US)

Members

• Gregg Alton, J.D.
  Executive Vice President, Corporate and Medical Affairs, Gilead Sciences
• Michael Arbige, Ph.D.
  Senior Vice President, Technology, Genencor International
• Robert Blum
  President and Chief Executive Officer, Cytokinetics
• Eugene Bauer, M.D.
  President and Chief Medical Officer, Peplin
• Laura Brege
  Executive Vice President & Chief Operating Officer, Onyx Pharmaceuticals, Inc.
• Robert Brigham
  Partner, Cooley Godward Kronish LLP
• Peter Calcott, Ph.D.
  Founder, Calcott Consulting
• Pierre Cassigneul
  President and Chief Executive Officer, XDx
• Peter Daly
  Senior Vice President, Wells Fargo
• Paulette DeFalco
  Western Area Life Sciences Leader, KPMG LLP
• Keith Donnermeyer
  Life Sciences and Healthcare Regional Managing Partner, Deloitte & Touche LLP
• Kareem Dossa
  Area Vice President of Sales, VWR International
• Steve Engle
  Chairman and Chief Executive Officer, XOMA, Inc.
• Tom Glaze
  Principal, Glaze Capital
• Hoyoung Huh, Ph.D., M.D.
• Steve James
  President and Chief Executive Officer, KAI Pharmaceuticals
• James Karis
• Todd Kaufman
  Director, State Government Affairs, Genentech
• David L. Lacey, M.D.
  Senior Vice-President, Amgen
• Caroline Loewy
  Chief Financial Officer, Corcept Therapeutics Inc.
• Gail Maderis
  President & Chief Executive Officer, BayBio
• David Martin, M.D.
  Chief Executive Officer, Avid Biotics and Member, Board of Directors, Varian Medical Systems and Cubist Pharmaceuticals
• John Melo
  Chief Executive Officer, Amyris
• Alan C. Mendelson
  Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP
• Susan Molineaux, Ph.D.
• Phil Moody
• Daniel O'Day
  President and Chief Executive Officer, Roche Molecular Diagnostics
• Lynn Pasahow, Esq.
  Partner, Fenwick & West LLP
• Jeffrey N. Peterson
  Chief Executive Officer, Target Discovery, Inc.
• Kim Popovits
  President and Chief Executive Officer, Genomic Health
• A. Franklin Rice
  Senior Vice President of Finance and Administration, VistaGen
• Steve Richardson
  Senior Vice President, Alexandria Real Estate Equities, Inc.
• Howard Robin
  President & Chief Executive Officer, NEKTAR
• George Scangos
  President & Chief Executive Officer, Exilixis, Inc
• Anthony Stolis
  Clarkston Consulting
• Stephen Thau
  Co-Chair Life Sciences Group, Morrison & Foerster
• Dan Welch
  Chairman, Chief Executive Officer and President, InterMune
• William Young
  Chairman Emeritus